Stocks and Investing
Stocks and Investing
Thu, April 23, 2015
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, April 22, 2015
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jason McCarthy Initiated (BLUE) at Strong Buy and Held Target at $190 on, Apr 22nd, 2015
Jason McCarthy of Maxim Group, Initiated "bluebird bio, Inc." (BLUE) at Strong Buy and Held Target at $190 on, Apr 22nd, 2015.
Jason has made no other calls on BLUE in the last 4 months.
There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Jason's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jason
- Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $117 on, Thursday, February 26th, 2015
Contributing Sources